Marty Makary

speaker

939 appearances 6 recordings 5 series first heard Jan 2026 last heard 13 May

Marty Makary’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 6 in all, peaking in Jan 2026 with 4.

newest first · ▶ plays the moment

Help us understand a little bit about the role that industry has in influencing some of this regulatory process.

My only criticism is the lack of vegetarian protein in the top of the pyramid, where as a vegetarian, I eat eggs and dairy.

It could use a few more nuts and beans up top.

Yes, it could.

I'll talk to Joe Gebbia about it.

It could.

The blueberries?

That was the criticism?

Yeah.

Okay.

That wasn't one that bothered me.

Let's talk about the adult population.

I think 40 to 60%, depending on how you measure it, are clinically obese in this country.

And these incretin memetics, GLP-1 drugs and others, have really taken the market by storm, taken our population by storm.

So I realize that much of this is in response to an obesity epidemic that we're facing in this country.

But it turns out that these incretin memetics may actually have other systemic benefits.

And they're now, I think there's 60 indications that they're being tested against, including kidney, neurological, cardiac.

I mean, there seems to be a lot of benefit potentially in using them for other disease indications.

Can you speak a little bit about your view on where this market, where this class of therapeutics is headed?

Is this something that some people have estimated are 60% of Americans are going to be on?

Showing 501–520 of 939 · page 26 of 47